MIDD+ Boston
May 6th – 7th, 2024
Boston Courtyard, Cambridge

The conference will be held in person, and there will be no hybrid option available.

Model-informed drug development (MIDD) is now standard in the pharmaceutical industry, but few organizations are reaping the full value of their technology investments.

That’s why we’re hosting MIDD+ Boston, a free two-day event where you can learn how industry peers across disciplines are getting deeper insight and actionable data using modeling and simulation (M&S) software. With a combination of scientific presentations and hands-on learning sessions, you and your team will come away with a strengthened understanding and skills for driving your program toward success.

You won’t want to miss keynote speaker Dr. Birgit Schoeberl (Novartis Institutes for BioMedical Research), or presentations from industry leaders including Wirong Wang (Janssen), Kishore Paskikanti (Grunenthal), Ka Ning Yip (Relay Therapeutics), Ridwan Islam (Crystal Pharmatech) and Xiyuan (Susie) Zhang (Daiichi Sankyo).

DAY 1: May 6th, 9:30 AM – 5:00 PM EDT

Hear from scientists at leading pharmaceutical companies explain how they use M&S to answer questions, inform critical program decisions, and support their regulatory submissions. They’ll share real-world examples, innovative ways they have been able to leverage the GastroPlus® platform, and how the functionality has informed their own internal processes.

DAY 2: May 7th, 9:30 AM – 4:30 PM EDT

Gain hands-on experience with GastroPlus X before its release. Our modeling and simulation experts will show you how to get the most out of this new platform.